4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0000899243-22-000691
Options or other derivatives
- Director acquired 2,256 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ros Matthew · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-03 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +2,256 | $5.15 | $11,625 | 2,256 | D |
Loading xslF345X03/doc4.xml…